Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MIGNONE ROBERTO −$14.4M Director sold 100% of stake
  2. Francis Richard D −$10.6M President and CEO sold 21% of stake
  3. Sabag Mark −$3.9M See "Remarks" sold 53% of stake
  4. Daniell Richard −$1.9M EVP, Europe Commercial sold 45% of stake
  5. Weiss Amir −$1.1M Chief Accounting Officer sold 88% of stake
Date Insider Transaction Shares Price Value Owned after
2018-02-09 Schultz Kare President and CEO Grant or award · Restricted Share Units +80,601 80,601
2018-02-09 O'Grady Brendan P. EVP, North America Commercial Grant or award · Stock Options (right to buy) +123,288 123,288
2018-02-09 O'Grady Brendan P. EVP, North America Commercial Grant or award · Restricted Share Units +48,361 48,361
2018-02-09 Nazzi Gianfranco EVP, Growth Markets Commercial Grant or award · Stock Options (right to buy) +91,326 91,326
2018-02-09 Nazzi Gianfranco EVP, Growth Markets Commercial Grant or award · Restricted Share Units +35,823 35,823
2018-02-09 McClellan Michael James EVP, Chief Financial Officer Grant or award · Stock Options (right to buy) +123,288 123,288
2018-02-09 McClellan Michael James EVP, Chief Financial Officer Grant or award · Restricted Share Units +48,361 48,361
2018-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Stock Options (right to buy) +123,288 123,288
2018-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +48,361 48,361
2018-02-09 Dethlefs Sven EVP Global Marketing&Portfolio Grant or award · Stock Options (right to buy) +100,457 100,457
2018-02-09 Dethlefs Sven EVP Global Marketing&Portfolio Grant or award · Restricted Share Units +39,405 39,405
2018-02-09 de Notaristefani Carlo Executive VP Global Operations Grant or award · Stock Options (right to buy) +159,819 159,819
2018-02-09 de Notaristefani Carlo Executive VP Global Operations Grant or award · Restricted Share Units +62,690 62,690
2018-02-09 Daniell Richard Exec. VP, European Commercial Grant or award · Stock Options (right to buy) +100,457 100,457
2018-02-09 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +39,405 39,405
2018-01-19 Suesskind Dan S Director Other acquisition +19,700 $25.00 $493K 318,836
2018-01-19 Suesskind Dan S Director Other disposition · Put Option (Obligation to buy) −19,700 0

Page 76 of 76 · 1,517 trades